InsiderClue
Insiders · Profile

LANKLER DOUGLAS M

Executive Vice President at Pfizer. Filing since 27 May 2011. CIK 0001488270

Company
Date
Role
Action
Shares
Amount
Of holding
PFE Pfizer
12 May 2022
Executive Vice President
Sold, plan not stated
38,273
$1.89M
32.7%
PFE Pfizer
26 Nov 2021
Executive Vice President
Sold, plan not stated
40,000
$2.17M
37.6%
PFE Pfizer
29 Apr 2020
Executive Vice President
Sold, plan not stated
65,000
$2.46M
45.4%
PFE Pfizer
1 Feb 2019
Executive Vice President
Sold, plan not stated
5,000
$213.75K
11.1%
PFE Pfizer
30 Jan 2019
Executive Vice President
Sold, plan not stated
38,800
$1.60M
46.3%
PFE Pfizer
13 Mar 2018
Executive Vice President
Sold, plan not stated
50,000
$1.84M
37.4%
PFE Pfizer
2 Mar 2017
Executive Vice President
Sold, plan not stated
20,000
$693.20K
19.3%
PFE Pfizer
4 May 2016
Executive Vice President
Sold, plan not stated
29,700
$1.00M
23.5%
PFE Pfizer
16 Sep 2013
Executive Vice President
Sold, plan not stated
60,900
$1.75M
40.4%
PFE Pfizer
13 Mar 2013
Executive Vice President
Sold, plan not stated
15,000
$420.06K
14.5%
PFE Pfizer
21 Nov 2012
Executive Vice President
Sold, plan not stated
11,970
$290.63K
11.7%
PFE Pfizer
11 May 2012
Executive Vice President
Sold, plan not stated
19,670
$450.05K
15.5%
PFE Pfizer
29 Aug 2011
Executive Vice President
Sold, plan not stated
9,000
$170.10K
7.4%
PFE Pfizer
23 Aug 2011
Executive Vice President
Sold, plan not stated
3,000
$54.00K
2.4%
PFE Pfizer
27 May 2011
Executive Vice President
Sold, plan not stated
7,541
$157.61K
7.8%
15 decisions on file.